Motta G, Sampaio C A, Sampaio M U
Department of Biochemistry, Escola Paulista de Medicina, São Paulo, Brazil.
Agents Actions Suppl. 1992;36:200-8.
Human plasma kallikrein (HuPK) is a serine protease found in mammalian plasma. Following limited proteolysis, the enzyme is activated and forms two chains. The light chain occurs with molecular weight 36,000 or 33,000 and contains the active site. The heavy chain occurs with molecular weight of 45,000 and contains the binding site for high-molecular-weight kininogen. Both chains were prepared from active HuPK, following mild reduction with dithiothreitol and carboxymethylation with iodoacetamide. The light chain was isolated in SBTI-Sepharose and its kinetic properties were determined with synthetic derivatives of arginine-p-nitroanilides, to investigate any possible alteration of the active site. These studies showed that substrate modifications affected the hydrolytic activity more than the binding capacity. The ability to cleave high-molecular-weight kininogen, as observed for intact kallikrein, was reduced in beta-kallikrein and absent in the light chain, even when equimolar amounts of both light and heavy chains were tested together. Anti-kallikrein antiserum formed immunoprecipitates not only with kallikrein itself, but also with the separated chains. The immunoreactivity of the light-chain was not identical with that of kallikrein. Immunoselected specific antibodies for both chains, depending on the selectivity, reacted with the heavy chain and kallikrein, or with the light chain and kallikrein. These antibodies were shown to be effective in binding radio-iodinated HuPK in the radioimmunoassay developed for intact kallikrein.
人血浆激肽释放酶(HuPK)是一种存在于哺乳动物血浆中的丝氨酸蛋白酶。经过有限的蛋白水解后,该酶被激活并形成两条链。轻链分子量为36,000或33,000,含有活性位点。重链分子量为45,000,含有高分子量激肽原的结合位点。两条链均由活性HuPK经二硫苏糖醇轻度还原和碘乙酰胺羧甲基化后制备得到。轻链在大豆胰蛋白酶抑制剂-琼脂糖中分离,并用精氨酸对硝基苯胺的合成衍生物测定其动力学性质,以研究活性位点是否有任何可能的改变。这些研究表明,底物修饰对水解活性的影响大于对结合能力的影响。完整激肽释放酶所具有的裂解高分子量激肽原的能力,在β-激肽释放酶中降低,在轻链中则不存在,即使同时测试等摩尔量的轻链和重链也是如此。抗激肽释放酶抗血清不仅能与激肽释放酶本身形成免疫沉淀,还能与分离的链形成免疫沉淀。轻链的免疫反应性与激肽释放酶不同。根据选择性,针对两条链的免疫选择特异性抗体分别与重链和激肽释放酶反应,或与轻链和激肽释放酶反应。在为完整激肽释放酶开发的放射免疫测定中,这些抗体被证明能有效结合放射性碘标记的HuPK。